MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1471-0528.2004.00340.x

Медицинская библиотека · BJOG : an international journal of obstetrics and gynaecology · 2005

Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.

Buhimschi Irina A, Christner Rob, Buhimschi Catalin S

СтатьяПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Intra-amniotic inflammation is associated with poor neonatal outcome independent of prematurity. We applied proteomic technology (SELDI: surface-enhanced laser desorption ionisation) to identify the proteomic profile of intra-amniotic inflammation.

DESIGN

One hundred and four samples of amniotic fluid were analysed. In stage 1, samples from patients with symptoms of preterm labour and known outcomes were tested to identify the characteristic profile for inflammation. We extracted the profile using a novel, stepwise logical approach comparing SELDI tracings from patients who delivered preterm and had intra-amniotic inflammation in response to infection to the tracings of patients who had symptoms of preterm labour but delivered at term. In stage 2, we applied the algorithm to samples from pregnancies whose outcomes were unknown to the investigators.

SETTING

North-American university in collaboration with Ciphergen field demonstration laboratory.

SAMPLE: One hundred and four samples of human amniotic fluid from transabdominal amniocentesis.

METHODS

SELDI (surface-enhanced laser desorption ionisation) and Mass Restricted analysis, a novel algorithm for extraction of clinical and biological relevant biomarkers from proteomic SELDI tracings.

MAIN OUTCOME MEASURE: Presence of intra-amniotic inflammation and/or infection leading to preterm birth.

RESULTS

Patients with intra-amniotic inflammation that deliver preterm have a distinctive amniotic fluid proteomic profile of three or four of the following proteins: neutrophil defensins-1 and -2, and calgranulins A and C. Based on the presence or absence of these biomarkers, we devised the mass restricted (MR) score ranging from 0 (all biomarker peaks absent) to 4 (all biomarker peaks present). In stage 1, MR score > 2 had 92.9% sensitivity (95% CI 76.5-98.9) and 91.8% specificity (95% CI 80.4-97.7) for detection of intra-amniotic inflammation. In blind testing (stage 2), MR score > 2 provided 100% specificity and sensitivity (95% CI 100-100). A MR score > 2 was associated with imminent preterm delivery.

CONCLUSION

Proteomic analysis of amniotic fluid reveals the presence of biomarkers characteristic of intrauterine inflammation. This methodology may identify the subgroup of patients that might benefit most from interventions to prevent fetal damage in utero.

Для цитирования: Buhimschi Irina A, Christner Rob, Buhimschi Catalin S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.. BJOG : an international journal of obstetrics and gynaecology. 2005. DOI: 10.1111/j.1471-0528.2004.00340.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.